---
$id: https://graph.org.ai/products/commodity/51123116
$type: Product
source: UNSPSC
code: "51123116"
title: "Procainamide hydrochloride"
class: "51123100"
classTitle: "Antiarrythmic amides"
family: "51120000"
familyTitle: "Antiarrythmics and antianginals and cardioplegics and drugs for heart failure"
segment: "51000000"
segmentTitle: "Pharmaceutical Products incl. Contraceptives and Vaccines"


---

# Procainamide hydrochloride

**UNSPSC Code**: 51123116
**Class**: [Antiarrythmic amides](Antiarrythmic amides.mdx)
**Family**: [Antiarrythmics and antianginals and cardioplegics and drugs for heart failure](../Antiarrythmics and antianginals and cardioplegics and drugs for heart failure.mdx)
**Segment**: [Pharmaceutical Products incl. Contraceptives and Vaccines](../../Pharmaceutical Products incl. Contraceptives and Vaccines.mdx)

This classification denotes a cation channel blocker and antiarrhythmic agent with the molecular formula C13H21N3O.ClH, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier SI4064O0LX, chemically known as benzamide, p-amino-n-(2-(diethylamino)ethyl)-, hydrochloride but more generally known as procainamide hydrochloride, which bears US NIH Compound Identifier 66068. European Medicines Agency schedules Procainamide hydrochloride in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB04045MIG. Most nations, for tariff and trade purposes, schedule procainamide hydrochloride under HS 29242995 and SITC 51479. As of Q4 2014, PROCAINAMIDE HYDROCHLORIDE remains US FDA's Preferred Term for this commodity. Procainamide hydrochloride bears US NLM identifiers UMLS ID C0699067 and NCI Concept Code C47687. SMILES: CCN(CC)CCNC(=O)C1CCC(CC1)N.CL.

